Perrigo Company plc - stock earnings

PRGO Upcoming estimated earnings

DateLow RevenueAverage RevenueHigh Revenue
May 7, 2024 BeforeMarket 1.1 billion 1.1 billion 1.1 billion

PRGO Quarterly earnings

DateEarningsRevenue
2023Q4 -32.3 million USD 1.2 billion USD
2023Q3 14.2 million USD 1.1 billion USD
2023Q2 8.4 million USD 1.2 billion USD
2023Q1 -1.1 million USD 1.2 billion USD
2022Q4 -12.7 million USD 1.2 billion USD
2022Q3 -52.1 million USD 1.1 billion USD
2022Q2 -64.9 million USD 1.1 billion USD
2022Q1 -1.3 million USD 1.1 billion USD
2021Q4 9.6 million USD 1.1 billion USD
2021Q3 -58.9 million USD 1.0 billion USD
2021Q2 -57.7 million USD 981.1 million USD
2021Q1 38.1 million USD 1.0 billion USD
2020Q4 -175.0 million USD 1.3 billion USD
2020Q3 -154.6 million USD 1.2 billion USD
2020Q2 60.6 million USD 1.2 billion USD
2020Q1 106.4 million USD 1.3 billion USD
2019Q4 -19.0 million USD 1.3 billion USD
2019Q3 92.2 million USD 1.2 billion USD
2019Q2 9.0 million USD 1.1 billion USD
2019Q1 63.9 million USD 1.2 billion USD
2018Q4 81.4 million USD 1.2 billion USD
2018Q3 -67.5 million USD 1.1 billion USD
2018Q2 36.2 million USD 1.2 billion USD
2018Q1 80.8 million USD 1.2 billion USD
2017Q4 73.2 million USD 1.3 billion USD
2017Q3 44.5 million USD 1.2 billion USD
2017Q2 -69.6 million USD 1.2 billion USD
2017Q1 -2.6 billion USD 1.1 billion USD
2016Q4 -2.6 billion USD 1.1 billion USD
2016Q3 -1.3 billion USD 1.4 billion USD
2016Q2 194.3 million USD 1.5 billion USD
2016Q1 -133.1 million USD 1.4 billion USD
2015Q4 -107.0 million USD 1.4 billion USD
2015Q3 112.6 million USD 1.3 billion USD
2015Q2 56.4 million USD 1.5 billion USD
2015Q1 -94.9 million USD 1.0 billion USD
2014Q4 70.2 million USD 1.1 billion USD
2014Q3 96.3 million USD 951.5 million USD
2014Q2 131.9 million USD 1.1 billion USD
2014Q1 48.1 million USD 1.0 billion USD
2013Q4 -86.0 million USD 979.0 million USD
2013Q3 111.4 million USD 933.4 million USD
2013Q2 118.4 million USD 967.2 million USD
2013Q1 111.9 million USD 919.8 million USD
2012Q4 106.0 million USD 883.0 million USD
2012Q3 105.6 million USD 769.8 million USD
2012Q2 115.7 million USD 831.8 million USD
2012Q1 115.7 million USD 778.0 million USD
2011Q4 99.7 million USD 838.2 million USD
2011Q3 70.5 million USD 725.3 million USD
2011Q2 85.6 million USD 704.6 million USD
2011Q1 89.1 million USD 691.6 million USD
2010Q4 90.2 million USD 717.5 million USD
2010Q3 74.4 million USD 641.3 million USD
2010Q2 49.4 million USD 619.4 million USD
2010Q1 60.9 million USD 538.3 million USD
2009Q4 50.9 million USD 583.2 million USD
2009Q3 61.3 million USD 528.0 million USD
2009Q2 35.2 million USD 508.2 million USD
2009Q1 45.9 million USD 505.9 million USD
2008Q4 25.0 million USD 561.5 million USD
2008Q3 38.0 million USD 480.2 million USD
2008Q2 27.5 million USD 500.2 million USD
2008Q1 40.0 million USD 503.7 million USD
2007Q4 34.3 million USD 435.5 million USD
2007Q3 34.0 million USD 382.7 million USD
2007Q2 18.8 million USD 374.3 million USD
2007Q1 17.1 million USD 362.3 million USD
2006Q4 21.1 million USD 370.6 million USD
2006Q3 16.9 million USD 340.2 million USD
2006Q2 12.3 million USD 355.1 million USD
2006Q1 20.9 million USD 332.3 million USD
2005Q4 25.4 million USD 359.7 million USD
2005Q3 12.9 million USD 319.7 million USD
2005Q2 -7.0 million USD 324.5 million USD
2005Q1 -379.4 million USD 220.1 million USD
2004Q4 15.8 million USD 251.7 million USD
2004Q3 17.6 million USD 227.7 million USD
2004Q2 8.1 million USD 212.6 million USD
2004Q1 17.7 million USD 230.7 million USD
2003Q4 38.2 million USD 245.1 million USD
2003Q3 16.5 million USD 209.8 million USD
2003Q2 4.3 million USD 182.6 million USD
2003Q1 14.1 million USD 202.6 million USD
2002Q4 16.8 million USD 227.5 million USD
2002Q3 20.0 million USD 213.2 million USD
2002Q2 1.3 million USD 182.0 million USD
2002Q1 19.3 million USD 198.5 million USD
2001Q4 16.6 million USD 228.7 million USD
2001Q3 13.1 million USD 217.1 million USD
2001Q2 6.2 million USD 177.3 million USD
2001Q1 10.1 million USD 192.0 million USD
2000Q4 820000 USD 190.9 million USD
2000Q3 10.5 million USD 193.3 million USD
2000Q2 -8.1 million USD 150.5 million USD
2000Q1 6.4 million USD 181.5 million USD
1999Q4 11.0 million USD 197.2 million USD
1999Q3 10.0 million USD 209.4 million USD
1999Q2 -3.0 million USD 187.8 million USD
1999Q1 9.7 million USD 251.4 million USD
1998Q4 7.1 million USD 226.1 million USD
1998Q3 -12.4 million USD 212.3 million USD
1998Q2 -88.7 million USD 214.4 million USD
1998Q1 9.5 million USD 223.7 million USD
1997Q4 14.4 million USD 240.7 million USD
1997Q3 13.2 million USD 223.8 million USD
1997Q2 9.0 million USD 196.2 million USD
1997Q1 11.6 million USD 214.6 million USD
1996Q4 13.7 million USD 221.7 million USD
1996Q3 10.7 million USD 212.2 million USD
1996Q2 4.8 million USD 175.6 million USD
1996Q1 10.6 million USD 196.3 million USD
1995Q4 12.2 million USD 201.0 million USD
1995Q3 12.2 million USD 205.1 million USD
1995Q2 5.4 million USD 174.4 million USD
1995Q1 11.4 million USD 185.3 million USD
1994Q4 12.9 million USD 174.7 million USD
1994Q3 14.8 million USD 182.7 million USD
1994Q2 11.6 million USD 158.2 million USD
1994Q1 13.3 million USD 163.6 million USD
1993Q4 15.3 million USD 174.4 million USD
1993Q3 14.6 million USD 173.1 million USD
1993Q2 11.2 million USD 144.7 million USD
1993Q1 11.3 million USD 142.2 million USD
1992Q4 11.8 million USD 141.0 million USD
1992Q3 10.4 million USD 142.9 million USD
1992Q2 7.6 million USD 108.8 million USD
1992Q1 8.2 million USD 120.8 million USD
1991Q4 6.7 million USD 93.0 million USD
1991Q3 ? USD 87.1 million USD

PRGO Yearly earnings

DateEarningsRevenue
2023 -12.7 million USD 4.7 billion USD
2022 -130.9 million USD 4.5 billion USD
2021 -130.9 million USD 4.1 billion USD
2020 -162.6 million USD 5.1 billion USD
2019 146.1 million USD 4.8 billion USD
2018 131.0 million USD 4.7 billion USD
2017 119.6 million USD 4.9 billion USD
2016 -4.0 billion USD 5.3 billion USD
2015 127.9 million USD 4.6 billion USD
2014 205.3 million USD 4.1 billion USD
2013 205.3 million USD 4.1 billion USD
2012 441.9 million USD 3.5 billion USD
2011 401.6 million USD 3.2 billion USD
2010 339.2 million USD 2.8 billion USD
2009 222.5 million USD 2.3 billion USD
2008 144.0 million USD 2.0 billion USD
2007 135.8 million USD 1.8 billion USD
2006 73.8 million USD 1.4 billion USD
2005 71.4 million USD 1.4 billion USD
2004 -353.0 million USD 1.0 billion USD
2003 80.6 million USD 898.2 million USD
2002 54.0 million USD 826.0 million USD
2001 50.2 million USD 826.3 million USD
2000 27.7 million USD 753.5 million USD
1999 19.3 million USD 738.6 million USD
1998 1.5 million USD 877.6 million USD
1997 -51.6 million USD 902.6 million USD
1996 45.0 million USD 844.6 million USD
1995 39.8 million USD 778.1 million USD
1994 44.4 million USD 717.1 million USD
1993 54.8 million USD 669.3 million USD
1992 44.6 million USD 570.8 million USD
1991 28.6 million USD 409.8 million USD

PRGO

List: Contenders

Price: 32.19USD

52 week price:
25.52
40.28

Dividend Yield: 3.47%

5-year range yield:
1.56%
4.19%

Forward Dividend Yield: 3.48%

Payout Ratio: 1365.00%

Payout Ratio Range:
-1867.22%
1365.00%

Dividend Per Share: 1.10 USD

Earnings Per Share: 0.08 USD

P/E Ratio: 394.50

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 680000

Ebitda: 274.7 million

Market Capitalization: 4.3 billion

Average Dividend Frequency: 4

Years Paying Dividends: 22

DGR3: 7.19%

DGR5: 9.50%

DGR10: 12.02%

Links: